Seeing Is Believing
Healthcare - Sector
with an average price target of $30.91. This is a potential upside of $30.91 (0%) from yesterday's end of day stock price of $0.
Genocea Biosciences's activity chart (see below) currently has 32 price targets and 32 ratings on display.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 32.1 days.
Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 29-Apr-2022. First documented stock forecast 05-Mar-2014.
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 29-Apr-2022
3 years 8 months 25 days ago
(29-Apr-2022)
0/2 (0%)
$10 (100.00%)
Hold
Since 29-Apr-2022
$0.16
$0.16 (0.00%)
$18
3 years 8 months 25 days ago
(29-Apr-2022)
1/3 (33.33%)
$-0.12 (-42.86%)
25
Hold
Since 29-Apr-2022
$9
3 years 8 months 25 days ago
(29-Apr-2022)
1/2 (50%)
$5.4 (150.00%)
4
Buy
Since 01-Mar-2019
4 years 11 months 12 days ago
(11-Feb-2021)
0/1 (0%)
$9.91 (162.73%)
Buy
Since 03-Jun-2019
$8
$8 (0.00%)
$15
5 years 5 months 24 days ago
(30-Jul-2020)
0/2 (0%)
$4.55 (131.88%)
What is GNCA (Genocea Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on GNCA (Genocea Biosciences) with a proven track record?
Which analyst has the most public recommendations on GNCA (Genocea Biosciences)?
Which analyst is the currently most bullish on GNCA (Genocea Biosciences)?
Which analyst is the currently most reserved on GNCA (Genocea Biosciences)?